<DOC>
	<DOCNO>NCT01578135</DOCNO>
	<brief_summary>This study conduct Europe . The aim study describe patient population therapeutic practice ( study phase I ) , assess efficacy growth adult height assess tolerance somatropin ( Norditropin® SimpleXx® ) ( study phase II ) .</brief_summary>
	<brief_title>French National Registry Children Born Small Gestational Age Treated With Somatropin</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<criteria>Born small gestational age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>